- Home
- PLBY vs FATE Comparison
PLBY vs FATE Comparison
Compare PLBY & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLBY
- FATE
- Stock Information
- Founded
- PLBY 1953
- FATE 2007
- Country
- PLBY United States
- FATE United States
- Employees
- PLBY N/A
- FATE N/A
- Industry
- PLBY Recreational Games/Products/Toys
- FATE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PLBY Consumer Discretionary
- FATE Health Care
- Exchange
- PLBY Nasdaq
- FATE Nasdaq
- Market Cap
- PLBY 138.1M
- FATE 129.5M
- IPO Year
- PLBY N/A
- FATE 2013
- Fundamental
- Price
- PLBY $1.87
- FATE $1.24
- Analyst Decision
- PLBY Buy
- FATE Hold
- Analyst Count
- PLBY 2
- FATE 7
- Target Price
- PLBY $1.85
- FATE $3.83
- AVG Volume (30 Days)
- PLBY 381.3K
- FATE 1.6M
- Earning Date
- PLBY 08-07-2025
- FATE 08-12-2025
- Dividend Yield
- PLBY N/A
- FATE N/A
- EPS Growth
- PLBY N/A
- FATE N/A
- EPS
- PLBY N/A
- FATE N/A
- Revenue
- PLBY $116,691,000.00
- FATE $13,335,000.00
- Revenue This Year
- PLBY $3.96
- FATE N/A
- Revenue Next Year
- PLBY $1.75
- FATE N/A
- P/E Ratio
- PLBY N/A
- FATE N/A
- Revenue Growth
- PLBY N/A
- FATE 105.85
- 52 Week Low
- PLBY $0.52
- FATE $0.66
- 52 Week High
- PLBY $2.44
- FATE $5.92
- Technical
- Relative Strength Index (RSI)
- PLBY 59.42
- FATE 55.43
- Support Level
- PLBY $1.73
- FATE $1.12
- Resistance Level
- PLBY $2.08
- FATE $1.19
- Average True Range (ATR)
- PLBY 0.11
- FATE 0.06
- MACD
- PLBY -0.00
- FATE 0.02
- Stochastic Oscillator
- PLBY 41.34
- FATE 71.43
About PLBY PLBY Group Inc.
PLBY Group Inc connects consumers around the world with products, services, and experiences to help them look good, feel good, and have fun. PLBY Group serves consumers in four categories: Style and Apparel, Digital Entertainment and Lifestyle, Sexual Wellness, and Beauty and Grooming. It operates through three segments Direct-to-Consumer, Licensing, and Digital Subscriptions and Content. It generates revenue through the sales of products and content services to consumers.
About FATE Fate Therapeutics Inc.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.